Cargando…

Diabetes and COVID-19: Diseases of racial, social and glucose intolerance

Diabetes and coronavirus disease 2019 (COVID-19) are worldwide pandemics that have had a major impact on public health throughout the globe. Risk factors for developing diabetes and having adverse outcomes of COVID-19 appear to be similar; metabolic factors (such as obesity), non-White ethnicity and...

Descripción completa

Detalles Bibliográficos
Autor principal:	Chowdhury, Tahseen A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958476/ https://www.ncbi.nlm.nih.gov/pubmed/33758642 http://dx.doi.org/10.4239/wjd.v12.i3.198

Ejemplares similares

Fasting and rapamycin: diabetes versus benevolent glucose intolerance
por: Blagosklonny, Mikhail V.
Publicado: (2019)

Glucose-6-Phosphate Dehydrogenase Deficiency: An Actionable Risk Factor for Patients with COVID-19?
por: Jamerson, Brenda D., et al.
Publicado: (2020)

Strengthening social protection for TB patients: Lessons from COVID-19
por: Singh, Poonam Khetrapal
Publicado: (2022)

Potential Mechanisms of the Improvement of Glucose Homeostasis in Type 2 Diabetes by Pomegranate Juice
por: Olvera-Sandoval, Carlos, et al.
Publicado: (2022)

Blueberries’ Impact on Insulin Resistance and Glucose Intolerance
por: Stull, April J.
Publicado: (2016)

Glucose Intolerance in Pregnancy and Future Risk of Pre-Diabetes or Diabetes
por: Retnakaran, Ravi, et al.
Publicado: (2008)

Unequally vulnerable: a food justice approach to racial disparities in COVID-19 cases
por: Alkon, Alison Hope, et al.
Publicado: (2020)

Why Racial Justice Matters in Radiation Oncology
por: Chapman, Christina Hunter, et al.
Publicado: (2020)

Glucose-Sparing Action of Ketones Boosts Functions Exclusive to Glucose in the Brain
por: Zilberter, Yuri, et al.
Publicado: (2020)

The Perceived Social Burden in Celiac Disease
por: Ciacci, Carolina, et al.
Publicado: (2015)

Glucose Intolerance after a Recent History of Gestational Diabetes
por: Benhalima, Katrien, et al.
Publicado: (2014)

Glucose-6-phosphate dehydrogenase inhibitor for treatment of severe COVID-19: Polydatin
por: Doustimotlagh, Amir Hossein, et al.
Publicado: (2021)

Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
por: Peñaloza, Hernán F., et al.
Publicado: (2021)

Review of inflammatory bowel disease and COVID-19
por: Sultan, Keith, et al.
Publicado: (2020)

Continuity of cancer care in the era of COVID-19 pandemic: Role of social media in low- and middle-income countries
por: Yadav, Sanjay Kumar, et al.
Publicado: (2021)

The effect of COVID-19 on Ramadan fasting in people with diabetes in East London 2020: The East London diabetes in Ramadan survey
por: Khan, Halima, et al.
Publicado: (2020)

Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism
por: Kumar, Anjali F., et al.
Publicado: (2008)

Using nano-selenium to combat Coronavirus Disease 2019 (COVID-19)?()
por: He, Lina, et al.
Publicado: (2021)

Liver diseases in COVID-19: Etiology, treatment and prognosis
por: Wu, Jian, et al.
Publicado: (2020)

Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
por: Sharma, Ashwani, et al.
Publicado: (2022)

Secreted Protein Acidic and Rich in Cysteine (SPARC) to Manage Coronavirus Disease-2019 (COVID-19) Pandemic and the Post-COVID-19 Health Crisis
por: Ghanemi, Abdelaziz, et al.
Publicado: (2023)

Residency Match Trends, Racial Disparity, and Matching Amid a Pandemic
por: Vassantachart, April, et al.
Publicado: (2020)

Gestational Diabetes Mellitus and the Long-Term Risk for Glucose Intolerance and Overweight in the Offspring: A Narrative Review
por: Nijs, Hannah, et al.
Publicado: (2020)

Coronavirus Disease 2019 (COVID-19) Crisis Measures: Health Protective Properties?
por: Ghanemi, Abdelaziz, et al.
Publicado: (2021)

Epidemic Diseases and Chinese Medicine: Example of SARS and COVID-19: Part Two
por: Dubois, Jean-Claude
Publicado: (2020)

Oral Limonite Supplement Ameliorates Glucose Intolerance in Diabetic and Obese Mice
por: Uchida, Akihiro, et al.
Publicado: (2021)

Racial Disparities and COVID-19: the Social Context
por: Marrett, Cora B.
Publicado: (2021)

Transplantation of betacellulin-transduced islets improves glucose intolerance in diabetic mice
por: Song, Mi-Young, et al.
Publicado: (2014)

Diabetes incidence and glucose intolerance prevalence increase with higher outdoor temperature
por: Blauw, Lisanne L, et al.
Publicado: (2017)

Proinsulin is sensitive to reflect glucose intolerance
por: Nakamura, Akinobu, et al.
Publicado: (2019)

Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes
por: Esposito, Pasquale, et al.
Publicado: (2023)

‘The names have changed, but the game’s the same’: artificial intelligence and racial policy in the USA
por: Wallace, R.
Publicado: (2021)

NAD(+) in COVID-19 and viral infections
por: Zheng, Minyan, et al.
Publicado: (2022)

Glucose as a Potential Key to Fuel Inflammation in Rheumatoid Arthritis
por: Masuko, Kayo
Publicado: (2022)

COVID-19 Immunopathology and the Central Nervous System: Implication for Multiple Sclerosis and Other Autoimmune Diseases with Associated Demyelination
por: Boziki, Marina Kleopatra, et al.
Publicado: (2020)

Considerations for Home-Based Treatment of Fabry Disease in Poland during the COVID-19 Pandemic and Beyond
por: Nowicki, Michał, et al.
Publicado: (2021)

Private Equity–Backed Hospital Investments and the Impact of the Coronavirus Disease 2019 (COVID-19) Epidemic
por: Lexa, Frank J., et al.
Publicado: (2020)

Type 2 diabetes as a disease of ectopic fat?
por: Sattar, Naveed, et al.
Publicado: (2014)

Autoimmune Disorders & COVID-19
por: Freire-de-Lima, Leonardo, et al.
Publicado: (2021)

COVID-19: The Vital Sign
por: Haranath, Sai Praveen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c2qne1v9dsdcoa2m8vq2kcb8ur